State Street’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $88.9M | Sell |
2,804,168
-593,545
| -17% | -$16.2M | ﹤0.01% | 1436 |
|
|
2025
Q4 | $92.3M | Buy |
3,397,713
+555,579
| +20% | +$14.6M | ﹤0.01% | 1404 |
|
|
2025
Q3 | $73.5M | Buy |
2,842,134
+436,639
| +18% | +$10.1M | ﹤0.01% | 1532 |
|
|
2025
Q2 | $49M | Sell |
2,405,495
-400,864
| -14% | -$7.8M | ﹤0.01% | 1695 |
|
|
2025
Q1 | $50.9M | Sell |
2,806,359
-428,602
| -13% | -$9.58M | ﹤0.01% | 1621 |
|
|
2024
Q4 | $81.7M | Buy |
3,234,961
+749,805
| +30% | +$20.4M | ﹤0.01% | 1460 |
|
|
2024
Q3 | $84.5M | Sell |
2,485,156
-173,932
| -7% | -$6.63M | ﹤0.01% | 1422 |
|
|
2024
Q2 | $98.4M | Sell |
2,659,088
-320,663
| -11% | -$12.1M | ﹤0.01% | 1271 |
|
|
2024
Q1 | $125M | Buy |
2,979,751
+602,425
| +25% | +$24.7M | 0.01% | 1167 |
|
|
2023
Q4 | $94.3M | Buy |
2,377,326
+84,475
| +4% | +$2.48M | ﹤0.01% | 1331 |
|
|
2023
Q3 | $63.1M | Sell |
2,292,851
-434,455
| -16% | -$13.6M | ﹤0.01% | 1477 |
|
|
2023
Q2 | $92.5M | Buy |
2,727,306
+424,781
| +18% | +$14.3M | ﹤0.01% | 1273 |
|
|
2023
Q1 | $82.8M | Buy |
2,302,525
+11,071
| +0.5% | +$478K | ﹤0.01% | 1312 |
|
|
2022
Q4 | $102M | Sell |
2,291,454
-880,124
| -28% | -$31.4M | 0.01% | 1147 |
|
|
2022
Q3 | $89.2M | Sell |
3,171,578
-57,274
| -2% | -$1.76M | 0.01% | 1179 |
|
|
2022
Q2 | $87M | Buy |
3,228,852
+546,124
| +20% | +$15.9M | 0.01% | 1266 |
|
|
2022
Q1 | $91.4M | Buy |
2,682,728
+314,688
| +13% | +$10.1M | ﹤0.01% | 1354 |
|
|
2021
Q4 | $91.5M | Buy |
2,368,040
+510,922
| +28% | +$22.3M | ﹤0.01% | 1366 |
|
|
2021
Q3 | $100M | Sell |
1,857,118
-237,100
| -11% | -$11.1M | 0.01% | 1258 |
|
|
2021
Q2 | $70M | Buy |
2,094,218
+217,241
| +12% | +$5.96M | ﹤0.01% | 1593 |
|
|
2021
Q1 | $38.7M | Buy |
1,876,977
+66,717
| +4% | +$1.53M | ﹤0.01% | 1931 |
|
|
2020
Q4 | $31.7M | Buy |
1,810,260
+1,784,873
| +7,031% | +$32.1M | ﹤0.01% | 1943 |
|
|
2020
Q3 | $376K | Buy |
+25,387
| New | +$297K | ﹤0.01% | 3605 |
|
|
2019
Q1 | – | Sell |
-8,976
| Closed | -$27K | – | 3746 |
|
|
2018
Q4 | $27K | Sell |
8,976
-2,041
| -19% | -$10K | ﹤0.01% | 3705 |
|
|
2018
Q3 | $76K | Sell |
11,017
-228
| -2% | -$1.6K | ﹤0.01% | 3670 |
|
|
2018
Q2 | $85K | Sell |
11,245
-140,847
| -93% | -$1.88M | ﹤0.01% | 3645 |
|
|
2018
Q1 | $5.31M | Buy |
152,092
+6,278
| +4% | +$243K | ﹤0.01% | 2766 |
|
|
2017
Q4 | $6.21M | Buy |
145,814
+17,459
| +14% | +$748K | ﹤0.01% | 2687 |
|
|
2017
Q3 | $5.5M | Sell |
128,355
-5
| -0% | -$187 | ﹤0.01% | 2761 |
|
|
2017
Q2 | $4.76M | Sell |
128,360
-173,310
| -57% | -$7.67M | ﹤0.01% | 2753 |
|
|
2017
Q1 | $16.3M | Buy |
301,670
+13,492
| +5% | +$703K | ﹤0.01% | 2090 |
|
|
2016
Q4 | $15.3M | Sell |
288,178
-28,341
| -9% | -$1.61M | ﹤0.01% | 2088 |
|
|
2016
Q3 | $19.2M | Sell |
316,519
-14,979
| -5% | -$933K | ﹤0.01% | 1796 |
|
|
2016
Q2 | $21.8M | Sell |
331,498
-239,250
| -42% | -$15.2M | ﹤0.01% | 1691 |
|
|
2016
Q1 | $32.4M | Buy |
570,748
+350,273
| +159% | +$39.4M | ﹤0.01% | 1398 |
|
|
2015
Q4 | $51.9M | Buy |
220,475
+7,739
| +4% | +$1.69M | 0.01% | 1167 |
|
|
2015
Q3 | $33.6M | Buy |
212,736
+39,839
| +23% | +$11.3M | ﹤0.01% | 1396 |
|
|
2015
Q2 | $65.4M | Buy |
172,897
+18,814
| +12% | +$7.47M | 0.01% | 1103 |
|
|
2015
Q1 | $64.4M | Sell |
154,083
-8,400
| -5% | -$3M | 0.01% | 1096 |
|
|
2014
Q4 | $44.5M | Sell |
162,483
-7,689
| -5% | -$1.91M | ﹤0.01% | 1286 |
|
|
2014
Q3 | $33.1M | Buy |
170,172
+12,507
| +8% | +$2.73M | ﹤0.01% | 1393 |
|
|
2014
Q2 | $38.6M | Buy |
157,665
+800
| +0.5% | +$181K | ﹤0.01% | 1364 |
|
|
2014
Q1 | $41.6M | Buy |
156,865
+11,467
| +8% | +$4.39M | ﹤0.01% | 1304 |
|
|
2013
Q4 | $52.8M | Sell |
145,398
-7,532
| -5% | -$2.9M | 0.01% | 1164 |
|
|
2013
Q3 | $81.3M | Sell |
152,930
-17,127
| -10% | -$5.87M | 0.01% | 897 |
|
|
2013
Q2 | $39.8M | Buy |
+170,057
| New | +$33.5M | 0.01% | 1248 |
|
Other funds holding CLDX
KCM
VCM
CC
EP
